Showing results (421-430 of 1,109) with videos related to

Sort By:
Pageof 111
Biochemical and Biophysical Research Communications|January 28, 2014
Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophyChristudas Morais, David M Small, David A Vesey, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 6, 2023
Oral vitamin D supplementation on the prevention of peritoneal dialysis-related peritonitis: A pilot randomised controlled trialYu-Hui Zhang, Xiao Xu, Hai-Chen Pi, et al.
Kidney International Reports|March 18, 2021
A Systematic Review and Meta-Analysis on Effects of Bicarbonate Therapy on Kidney OutcomesSebastian Hultin, Chris Hood, Katrina L Campbell, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 2, 2020
Comparative Effectiveness of Calcimimetic Agents for Secondary Hyperparathyroidism in Adults: A Systematic Review and Network Meta-analysisSuetonia C Palmer, Dimitris Mavridis, David W Johnson, et al.
Growth Factors (Chur, Switzerland)|January 10, 2003
Interacting roles of myofibroblasts, apoptosis and fibrogenic growth factors in the pathogenesis of renal tubulo-interstitial fibrosisAnnette Lane, David W Johnson, Betty Pat, et al.
The Cochrane Database of Systematic Reviews|December 15, 2020
Urgent-start peritoneal dialysis versus conventional-start peritoneal dialysis for people with chronic kidney diseaseHtay Htay, David W Johnson, Jonathan C Craig, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|June 30, 2025
Hypokalaemia and peritoneal dialysis-related peritonitis: Association, risk factors and outcomesShabana Kalla, David W Johnson, Christine Chang, et al.
The Cochrane Database of Systematic Reviews|January 27, 2021
Urgent-start peritoneal dialysis versus haemodialysis for people with chronic kidney diseaseHtay Htay, David W Johnson, Jonathan C Craig, et al.
Kidney International Reports|March 8, 2022
Corrigendum to Ng MS, Malacova E, Hurst C, David MC, Johnson DW, Mallett AJ. "Clinical Outcomes of People With Fabry Disease - ANZDATA Registry Study." Kidney Int Rep. 2021;6:2481-2485Monica S Ng, Eva Malacova, Cameron Hurst, et al.
Phytochemistry|February 22, 2005
Mass spectral characterization of fatty acid amides from alfalfa trichomes and their deterrence against the potato leafhopperChristopher M Ranger, Rudolph E K Winter, George E Rottinghaus, et al.
Pageof 111